Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the launch of CARTO™ 3 System Version 8, the latest version of the company's ...

Johnson & Johnson MedTech’s Biosense Webster today announced the launch of the latest version of its Carto 3 heart mapping system.

Johnson & Johnson MedTech’s Biosense Webster division is rolling out a new version of its heart-mapping system that the company says marks its first to employ artificial intelligence capabilities. The ...

Johnson & Johnson MedTech division Biosense Webster has secured European CE mark approval for its Varipulse pulsed field ...

Paid and presented by Biosense Webster. Atrial fibrillation (AFib) is fast becoming one of the world’s most significant health issues, affecting millions worldwide, but it is also one of the ...

A West Village café Hungry Llama, in an out-of-the-way location, is trying to use a community model to engender customer ...

In this interview, Dr. Fu Wei, Director of Quality Management Department at BGI Genomics talks to AZoMedical about achieving and maintaining ISO/IEC 27001 and BS 10012 certifications. Isaac ...

This transformation involved a combination of internal initiatives, such as launching new products under Biosense Webster and acquisitions. These efforts and strong procedure volumes led to a ...

Report Ocean (150+ country’s markets analyzed, function on 1,00000+ published and forthcoming reports every year.] presents a ...

Global Atrial Fibrillation Market generated revenue of US$ 3,310.1 million in 2022 and is estimated to reach a valuation of US$ 6,839.8 million by 2031 at a CAGR of 8.71% during the forecast period, ...

The "Cardiac Ablation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ...